EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Current Status of COVID-19-Associated Secondary Bacterial and Fungal Infection: A Mini Review

D. Jayakumar, P. Kumar, M. Mini, S. Khan

Acta Microbiologica Bulgarica · 2023

DOI: 10.59393/amb23390201 ↗
AbstractBibliografische Angaben

Abstract

More than 550 million individuals have been affected by the devastating COVID-19 epidemic, claim¬ing more than 6.3 million lives worldwide. Secondary bacterial or fungal infections are one of the signifi¬cant manifestations of COVID-19 pneumonia. This mini review aims to understand the current status of secondary bacterial or fungal infections in COVID-19 patients. The prevalence of secondary bacterial or fungal infections or co-infections is one of the significant factors influencing mortality among COVID-19 patients. Secondary infections are caused by various bacterial and fungal pathogens, including Klebsiella pneumoniae, Acinetobacter spp., Pseudomonas spp., Enterococcus spp., Staphylococcus spp., Candida spp., Aspergillus spp., Cryptococcus spp. and Mucormycetes. Anti-microbial treatment is more challenging in COVID-19 pandemic because multidrug-resistant organisms cause most secondary microbial infections. The continuous monitoring of the prevalence and emergence of antibiotic-resistant bacteria and rational use of antibiotics are warranted during pandemic times.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →